Similar articles

• The effects of aldosterone on renin release in the isolated bloodless perfused canine kidney.

  Greco JM, Murphy GP. Greco JM, et al. Invest Urol. 1972 Jan;9(4):294-9. Invest Urol. 1972. PMID: 5058768 No abstract available.
• Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.

  Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T. Taira M, et al. Eur J Pharmacol. 2008 Jul 28;589(1-3):264-71. doi: 10.1016/j.ejphar.2008.06.019. Epub 2008 Jun 10. Eur J Pharmacol. 2008. PMID: 18582458
• Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist.

  Van Belle E, Bauters C, Wernert N, Hamon M, McFadden EP, Racadot A, Dupuis B, Lablanche JM, Bertrand ME. Van Belle E, et al. Cardiovasc Res. 1995 Jan;29(1):27-32. Cardiovasc Res. 1995. PMID: 7895235
• The kidney and the secretion of aldosterone.

  Peart WS. Peart WS. Adv Nephrol Necker Hosp. 1974;3:289-95. Adv Nephrol Necker Hosp. 1974. PMID: 4377517 Review. No abstract available.
• The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.

  Brewster UC, Perazella MA. Brewster UC, et al. Am J Med. 2004 Feb 15;116(4):263-72. doi: 10.1016/j.amjmed.2003.09.034. Am J Med. 2004. PMID: 14969655 Review.